These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38131289)
1. Radiotherapy-Triggered In Situ Tumor Vaccination Boosts Checkpoint Blockaded Immune Response via Antigen-Capturing Nanoadjuvants. Xu P; Ma J; Zhou Y; Gu Y; Cheng X; Wang Y; Wang Y; Gao M ACS Nano; 2024 Jan; 18(1):1022-1040. PubMed ID: 38131289 [TBL] [Abstract][Full Text] [Related]
2. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree. Sheen MR; Fiering S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346 [TBL] [Abstract][Full Text] [Related]
3. Metal-Coordinated NIR-II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming. Dai Y; Guo Z; Leng D; Jiao G; Chen K; Fu M; Liu Y; Shen Q; Wang Q; Zhu L; Zhao Q Adv Sci (Weinh); 2024 Sep; 11(34):e2404886. PubMed ID: 38973161 [TBL] [Abstract][Full Text] [Related]
4. Self-Immolated Nanoadjuvant for In Situ Vaccination Immunotherapy of Colorectal Cancer. Wang W; Zhu Q; Jin Y; Gao J; Li J; Zheng X; Gao W; Saeed M; Sheng W; Yu H Adv Healthc Mater; 2023 Sep; 12(23):e2300524. PubMed ID: 37269141 [TBL] [Abstract][Full Text] [Related]
5. Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy. Liu D; Fu L; Gong L; Li S; Li K; Liu K; Yang D ACS Appl Mater Interfaces; 2024 Feb; 16(7):8403-8416. PubMed ID: 38334116 [TBL] [Abstract][Full Text] [Related]
6. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade. Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333 [TBL] [Abstract][Full Text] [Related]
7. Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy. Yang A; Bai Y; Dong X; Ma T; Zhu D; Mei L; Lv F Acta Biomater; 2021 Oct; 133():257-267. PubMed ID: 34407475 [TBL] [Abstract][Full Text] [Related]
9. Radioactive Hydroxyapatite Microspheres Empower Sustainable Xu P; Gu Y; Li C; Shen J; Cheng X; Zhang LW; Wang Y; Wang Y ACS Nano; 2024 Jul; 18(28):18425-18443. PubMed ID: 38975713 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365 [TBL] [Abstract][Full Text] [Related]
11. Hollow Aluminum Hydroxide Modified Silica Nanoadjuvants with Amplified Immunotherapy Effects through Immunogenic Cell Death Induction and Antigen Release. Tan J; Ding B; Zheng P; Chen H; Ma P; Lin J Small; 2022 Aug; 18(34):e2202462. PubMed ID: 35896867 [TBL] [Abstract][Full Text] [Related]
12. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy. Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118 [TBL] [Abstract][Full Text] [Related]
14. Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination. Feng W; Shi W; Cui Y; Xu J; Liu S; Gao H; Zhu S; Liu Y; Zhang H Theranostics; 2023; 13(15):5266-5289. PubMed ID: 37908730 [TBL] [Abstract][Full Text] [Related]
15. Using nanoparticles for Gorbet MJ; Singh A; Mao C; Fiering S; Ranjan A Int J Hyperthermia; 2020 Dec; 37(3):18-33. PubMed ID: 33426995 [TBL] [Abstract][Full Text] [Related]
16. Cheng Y; Lemke-Miltner CD; Wongpattaraworakul W; Wang Z; Chan CHF; Salem AK; Weiner GJ; Simons AL J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060147 [TBL] [Abstract][Full Text] [Related]
17. Combining High-Z Sensitized Radiotherapy with CD73 Blockade to Boost Tumor Immunotherapy. Chen Q; Chen J; Zhang Q; Yang P; Gu R; Ren H; Dai Y; Huang S; Wu J; Wu X; Hu Y; Yuan A ACS Nano; 2023 Jul; 17(13):12087-12100. PubMed ID: 37327456 [TBL] [Abstract][Full Text] [Related]
18. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer. Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344 [TBL] [Abstract][Full Text] [Related]
19. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment. Zhao H; Zhao B; Wu L; Xiao H; Ding K; Zheng C; Song Q; Sun L; Wang L; Zhang Z ACS Nano; 2019 Nov; 13(11):12553-12566. PubMed ID: 31689085 [TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy. Ni K; Luo T; Nash GT; Lin W Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]